+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Non-opioid Pain Patches Market Size, Share & Trends Analysis Report By Patch Type (Lidocaine, Diclofenac, Methyl Salicylate, Capsaicin, Ketoprofen), By Distribution Channel, By Region, And Segment Forecasts, 2025 - 2030

  • PDF Icon

    Report

  • 100 Pages
  • November 2024
  • Region: Global
  • Grand View Research
  • ID: 6032399
The global non-opioid pain patches market size is expected to reach USD 1.4 billion by 2030, expanding at a CAGR of 6.2% during the forecast period. Some of the key factors driving the market are rising incidence of pain related disorders and the various benefits offered by these patches over other forms of medication used to alleviate acute and chronic pain.

According to the AAPM, chronic pain affects more individuals than cancer, diabetes, and coronary heart disease combined in the U.S. Estimates from the American Chiropractic Association indicate that American citizens spend at least USD 50 billion every year on back-related ailments. These facts are indicative of the growing need for therapies to alleviate pain globally.

Opioid medications are usually sought for the treatment of pain and related disorders despite resulting in dependence and abuse in majority of patients. The rising addiction to opioid drugs has encouraged many countries to develop alternate therapies to alleviate discomfort. In November 2017, opioid epidemic in the U.S. was declared as a national emergency. Thus, demand for safe and effective therapies that ease the underlying discomfort with reduced adverse effects are sought by governments, thus accelerating the market growth.

According to a new study published by Substance Abuse and Mental Health Services Administration report in 2015, 1 in 3 adults in America were prescribed painkillers by medical providers. Statistics from the same source also indicate that these medications were used more than cigarettes, cigars, and smokeless tobacco combined. Most of these oral medicines fall under the opiate category are usually more prone to be addictive and used in combination with other consumables such as alcohol and other drugs. Growing awareness about the adverse effects associated with these drugs has led to the development of alternatives such as non-opioid pain patches to deliver the same therapeutic effect and aid in pain management.

Non-opioid Pain Patches Market Report Highlights

  • Licodaine patches held the largest market share of 35.0% in 2024, owing to their established efficacy in alleviating various pain types, including neuropathic and musculoskeletal pain.
  • Retail pharmacies dominated the market with a revenue share of 44.6% in 2024. A variety of non-opioid pain patches are available over-the-counter, enabling customers to purchase them without prescriptions.
  • North America held the largest revenue share due to local presence of major non-opioid pain patch market players and increasing R&D in the field of pain management to cater to a rising number of patients
  • The Asia Pacific region is expected to account for the highest CAGR during the forecast period owing to rise in investments by dominant players in the region and developments in the pharmaceutical industry in emerging countries such as India and China

Why should you buy this report?

  • Comprehensive Market Analysis: Gain detailed insights into the global market across major regions and segments.
  • Competitive Landscape: Explore the market presence of key players worldwide.
  • Future Trends: Discover the pivotal trends and drivers shaping the future of the global market.
  • Actionable Recommendations: Utilize insights to uncover new revenue streams and guide strategic business decisions.

This report addresses:

  • Market intelligence to enable effective decision-making
  • Market estimates and forecasts from 2018 to 2030
  • Growth opportunities and trend analyses
  • Segment and regional revenue forecasts for market assessment
  • Competition strategy and market share analysis
  • Product innovation listing for you to stay ahead of the curve
  • COVID-19's impact and how to sustain in these fast-evolving markets

This product will be delivered within 1-3 business days.

Table of Contents

Chapter 1. Methodology and Scope
1.1. Market Segmentation & Scope
1.2. Segment Definitions
1.2.1. Patch Type
1.2.2. Distribution Channel
1.3. Estimates and Forecast Timeline
1.4. Research Methodology
1.5. Information Procurement
1.5.1. Purchased Database
1.5.2. Internal Database
1.5.3. Secondary Sources
1.5.4. Primary Research
1.6. Information Analysis
1.6.1. Data Analysis Models
1.7. Market Formulation & Data Visualization
1.8. Model Details
1.8.1. Commodity Flow Analysis
1.9. List of Secondary Sources
1.10. Objectives
Chapter 2. Executive Summary
2.1. Market Snapshot
2.2. Segment Snapshot
2.3. Competitive Landscape Snapshot
Chapter 3. Non-opioid Pain Patches Market Variables, Trends, & Scope
3.1. Market Lineage Outlook
3.2. Market Dynamics
3.2.1. Market Driver Analysis
3.2.2. Market Restraint Analysis
3.3. Business Environment Analysis
3.3.1. Industry Analysis - Porter’s Five Forces Analysis
3.3.1.1. Supplier Power
3.3.1.2. Buyer Power
3.3.1.3. Substitution Threat
3.3.1.4. Threat of New Entrants
3.3.1.5. Competitive Rivalry
3.3.2. PESTLE Analysis
Chapter 4. Non-opioid Pain Patches Market: Patch Type Business Analysis
4.1. Patch Type Market Share, 2024 & 2030
4.2. Patch Type Segment Dashboard
4.3. Market Size & Forecasts and Trend Analysis, by Patch Type, 2018 to 2030 (USD Million)
4.4. Lidocaine Patches
4.4.1. Lidocaine Patches Market, 2018 - 2030 (USD Million)
4.5. Diclofenac Patches
4.5.1. Diclofenac Patches Market, 2018 - 2030 (USD Million)
4.6. Methyl Salicylate Patches
4.6.1. Methyl Salicylate Patches Market, 2018 - 2030 (USD Million)
4.7. Capsaicin Patches
4.7.1. Capsaicin Patches Market, 2018 - 2030 (USD Million)
4.8. Ketoprofen Patches
4.8.1. Ketoprofen Patches Market, 2018 - 2030 (USD Million)
4.9. Others (Herbal, Menthol, etc.)
4.9.1. Others (Herbal, Menthol, etc.) Market, 2018 - 2030 (USD Million)
Chapter 5. Non-opioid Pain Patches Market: Distribution Channel Business Analysis
5.1. Distribution Channel Market Share, 2024 & 2030
5.2. Distribution Channel Segment Dashboard
5.3. Market Size & Forecasts and Trend Analysis, by Distribution Channel, 2018 to 2030 (USD Million)
5.4. Retail Pharmacies
5.4.1. Retail Pharmacies Market, 2018 - 2030 (USD Million)
5.5. Hospital Pharmacies
5.5.1. Hospital Pharmacies Market, 2018 - 2030 (USD Million)
5.6. Online Pharmacies
5.6.1. Online Pharmacies Market, 2018 - 2030 (USD Million)
5.7. Others (Supermarkets/Hypermarkets, DTC)
5.7.1. Others (Supermarkets/Hypermarkets, DTC) Market, 2018 - 2030 (USD Million)
Chapter 6. Non-opioid Pain Patches Market: Regional Estimates & Trend Analysis by Patch Type and Distribution Channel
6.1. Regional Market Share Analysis, 2024 & 2030
6.2. Regional Market Dashboard
6.3. Market Size, & Forecasts Trend Analysis, 2018 to 2030:
6.4. North America
6.4.1. North America Non-opioid Pain Patches Market Estimates And Forecasts, By Country, 2018 - 2030 (USD Million)
6.4.2. U.S.
6.4.2.1. Key Country Dynamics
6.4.2.2. Regulatory Framework
6.4.2.3. Competitive Insights
6.4.2.4. U.S. Non-opioid Pain Patches Market Estimates And Forecasts, 2018 - 2030 (USD Million)
6.4.3. Canada
6.4.3.1. Key Country Dynamics
6.4.3.2. Regulatory Framework
6.4.3.3. Competitive Insights
6.4.3.4. Canada Non-opioid Pain Patches Market Estimates And Forecasts, 2018 - 2030 (USD Million)
6.4.4. Mexico
6.4.4.1. Key Country Dynamics
6.4.4.2. Regulatory Framework
6.4.4.3. Competitive Insights
6.4.4.4. Mexico Non-opioid Pain Patches Market Estimates And Forecasts, 2018 - 2030 (USD Million)
6.5. Europe
6.5.1. Europe Non-opioid Pain Patches Market Estimates And Forecasts, By Country, 2018 - 2030 (USD Million)
6.5.2. UK
6.5.2.1. Key Country Dynamics
6.5.2.2. Regulatory Framework
6.5.2.3. Competitive Insights
6.5.2.4. UK Non-opioid Pain Patches Market Estimates And Forecasts, 2018 - 2030 (USD Million)
6.5.3. Germany
6.5.3.1. Key Country Dynamics
6.5.3.2. Regulatory Framework
6.5.3.3. Competitive Insights
6.5.3.4. Germany Non-opioid Pain Patches Market Estimates And Forecasts, 2018 - 2030 (USD Million)
6.5.4. France
6.5.4.1. Key Country Dynamics
6.5.4.2. Regulatory Framework
6.5.4.3. Competitive Insights
6.5.4.4. France Non-opioid Pain Patches Market Estimates And Forecasts, 2018 - 2030 (USD Million)
6.5.5. Italy
6.5.5.1. Key Country Dynamics
6.5.5.2. Regulatory Framework
6.5.5.3. Competitive Insights
6.5.5.4. Italy Non-opioid Pain Patches Market Estimates And Forecasts, 2018 - 2030 (USD Million)
6.5.6. Spain
6.5.6.1. Key Country Dynamics
6.5.6.2. Regulatory Framework
6.5.6.3. Competitive Insights
6.5.6.4. Spain Non-opioid Pain Patches Market Estimates And Forecasts, 2018 - 2030 (USD Million)
6.5.7. Norway
6.5.7.1. Key Country Dynamics
6.5.7.2. Regulatory Framework
6.5.7.3. Competitive Insights
6.5.7.4. Norway Non-opioid Pain Patches Market Estimates And Forecasts, 2018 - 2030 (USD Million)
6.5.8. Denmark
6.5.8.1. Key Country Dynamics
6.5.8.2. Regulatory Framework
6.5.8.3. Competitive Insights
6.5.8.4. Denmark Non-opioid Pain Patches Market Estimates And Forecasts, 2018 - 2030 (USD Million)
6.5.9. Sweden
6.5.9.1. Key Country Dynamics
6.5.9.2. Regulatory Framework
6.5.9.3. Competitive Insights
6.5.9.4. Sweden Non-opioid Pain Patches Market Estimates And Forecasts, 2018 - 2030 (USD Million)
6.6. Asia Pacific
6.6.1. Asia Pacific Non-opioid Pain Patches Market Estimates And Forecasts, By Country, 2018 - 2030 (USD Million)
6.6.2. Japan
6.6.2.1. Key Country Dynamics
6.6.2.2. Regulatory Framework
6.6.2.3. Competitive Insights
6.6.2.4. Japan Non-opioid Pain Patches Market Estimates And Forecasts, 2018 - 2030 (USD Million)
6.6.3. China
6.6.3.1. Key Country Dynamics
6.6.3.2. Regulatory Framework
6.6.3.3. Competitive Insights
6.6.3.4. China Non-opioid Pain Patches Market Estimates And Forecasts, 2018 - 2030 (USD Million)
6.6.4. India
6.6.4.1. Key Country Dynamics
6.6.4.2. Regulatory Framework
6.6.4.3. Competitive Insights
6.6.4.4. India Non-opioid Pain Patches Market Estimates And Forecasts, 2018 - 2030 (USD Million)
6.6.5. South Korea
6.6.5.1. Key Country Dynamics
6.6.5.2. Regulatory Framework
6.6.5.3. Competitive Insights
6.6.5.4. South Korea Non-opioid Pain Patches Market Estimates And Forecasts, 2018 - 2030 (USD Million)
6.6.6. Australia
6.6.6.1. Key Country Dynamics
6.6.6.2. Regulatory Framework
6.6.6.3. Competitive Insights
6.6.6.4. Australia Non-opioid Pain Patches Market Estimates And Forecasts, 2018 - 2030 (USD Million)
6.6.7. Thailand
6.6.7.1. Key Country Dynamics
6.6.7.2. Regulatory Framework
6.6.7.3. Competitive Insights
6.6.7.4. Thailand Non-opioid Pain Patches Market Estimates And Forecasts, 2018 - 2030 (USD Million)
6.7. Latin America
6.7.1. Latin America Non-opioid Pain Patches Market Estimates And Forecasts, By Country, 2018 - 2030 (USD Million)
6.7.2. Brazil
6.7.2.1. Key Country Dynamics
6.7.2.2. Regulatory Framework
6.7.2.3. Competitive Insights
6.7.2.4. Brazil Non-opioid Pain Patches Market Estimates And Forecasts, 2018 - 2030 (USD Million)
6.7.3. Argentina
6.7.3.1. Key Country Dynamics
6.7.3.2. Regulatory Framework
6.7.3.3. Competitive Insights
6.7.3.4. Argentina Non-opioid Pain Patches Market Estimates And Forecasts, 2018 - 2030 (USD Million)
6.8. MEA
6.8.1. MEA Non-opioid Pain Patches Market Estimates And Forecasts, By Country, 2018 - 2030 (USD Million)
6.8.2. South Africa
6.8.2.1. Key Country Dynamics
6.8.2.2. Regulatory Framework
6.8.2.3. Competitive Insights
6.8.2.4. South Africa Non-opioid Pain Patches Market Estimates And Forecasts, 2018 - 2030 (USD Million)
6.8.3. Saudi Arabia
6.8.3.1. Key Country Dynamics
6.8.3.2. Regulatory Framework
6.8.3.3. Competitive Insights
6.8.3.4. Saudi Arabia Non-opioid Pain Patches Market Estimates And Forecasts, 2018 - 2030 (USD Million)
6.8.4. UAE
6.8.4.1. Key Country Dynamics
6.8.4.2. Regulatory Framework
6.8.4.3. Competitive Insights
6.8.4.4. UAE Non-opioid Pain Patches Market Estimates And Forecasts, 2018 - 2030 (USD Million)
6.8.5. Kuwait
6.8.5.1. Key Country Dynamics
6.8.5.2. Regulatory Framework
6.8.5.3. Competitive Insights
6.8.5.4. Kuwait Non-opioid Pain Patches Market Estimates And Forecasts, 2018 - 2030 (USD Million)
Chapter 7. Competitive Landscape
7.1. Participant Overview
7.2. Company Market Position Analysis
7.3. Company Categorization
7.4. Strategy Mapping
7.5. Company Profiles/Listing
7.5.1. Acorda Therapeutics, Inc.
7.5.1.1. Overview
7.5.1.2. Financial Performance
7.5.1.3. Product Benchmarking
7.5.1.4. Strategic Initiatives
7.5.2. Teva Pharmaceutical Industries Ltd.
7.5.2.1. Overview
7.5.2.2. Financial Performance
7.5.2.3. Product Benchmarking
7.5.2.4. Strategic Initiatives
7.5.3. GSK plc
7.5.3.1. Overview
7.5.3.2. Financial Performance
7.5.3.3. Product Benchmarking
7.5.3.4. Strategic Initiatives
7.5.4. Endo, Inc.
7.5.4.1. Overview
7.5.4.2. Financial Performance
7.5.4.3. Product Benchmarking
7.5.4.4. Strategic Initiatives
7.5.5. Hisamitsu Pharmaceutical Co.,Inc.
7.5.5.1. Overview
7.5.5.2. Financial Performance
7.5.5.3. Product Benchmarking
7.5.5.4. Strategic Initiatives
7.5.6. IBSA Institut Biochimique SA
7.5.6.1. Overview
7.5.6.2. Financial Performance
7.5.6.3. Product Benchmarking
7.5.6.4. Strategic Initiatives
7.5.7. Alkermes
7.5.7.1. Overview
7.5.7.2. Financial Performance
7.5.7.3. Product Benchmarking
7.5.7.4. Strategic Initiatives
7.5.8. Teikoku Pharma
7.5.8.1. Overview
7.5.8.2. Financial Performance
7.5.8.3. Product Benchmarking
7.5.8.4. Strategic Initiatives
7.5.9. Mylan N.V.
7.5.9.1. Overview
7.5.9.2. Financial Performance
7.5.9.3. Product Benchmarking
7.5.9.4. Strategic Initiatives
List of Tables
Table 1 List of secondary sources
Table 2 List of abbreviations
Table 3 Global non-opioid pain patches market, by region, 2018 - 2030 (USD Million)
Table 4 Global non-opioid pain patches market, by patch type, 2018 - 2030 (USD Million)
Table 5 Global non-opioid pain patches market, by distribution channel, 2018 - 2030 (USD Million)
Table 6 North America non-opioid pain patches market, by country, 2018 - 2030 (USD Million)
Table 7 North America non-opioid pain patches market, by patch type, 2018 - 2030 (USD Million)
Table 8 North America non-opioid pain patches market, by distribution channel, 2018 - 2030 (USD Million)
Table 9 U.S. non-opioid pain patches market, by patch type, 2018 - 2030 (USD Million)
Table 10 U.S. Non-opioid pain patches market, by distribution channel, 2018 - 2030 (USD Million)
Table 11 Canada non-opioid pain patches market, by patch type, 2018 - 2030 (USD Million)
Table 12 Canada non-opioid pain patches market, by distribution channel, 2018 - 2030 (USD Million)
Table 13 Mexico non-opioid pain patches market, by patch type, 2018 - 2030 (USD Million)
Table 14 Mexico non-opioid pain patches market, by distribution channel, 2018 - 2030 (USD Million)
Table 15 Europe non-opioid pain patches market, by country, 2018 - 2030 (USD Million)
Table 16 Europe non-opioid pain patches market, by patch type, 2018 - 2030 (USD Million)
Table 17 Europe non-opioid pain patches market, by distribution channel, 2018 - 2030 (USD Million)
Table 18 UK non-opioid pain patches market, by patch type, 2018 - 2030 (USD Million)
Table 19 UK non-opioid pain patches market, by distribution channel, 2018 - 2030 (USD Million)
Table 20 Germany non-opioid pain patches market, by patch type, 2018 - 2030 (USD Million)
Table 21 Germany non-opioid pain patches market, by distribution channel, 2018 - 2030 (USD Million)
Table 22 France non-opioid pain patches market, by patch type, 2018 - 2030 (USD Million)
Table 23 France Non-opioid pain patches market, by distribution channel, 2018 - 2030 (USD Million)
Table 24 Italy non-opioid pain patches market, by patch type, 2018 - 2030 (USD Million)
Table 25 Italy non-opioid pain patches market, by distribution channel, 2018 - 2030 (USD Million)
Table 26 Spain non-opioid pain patches market, by patch type, 2018 - 2030 (USD Million)
Table 27 Spain non-opioid pain patches market, by distribution channel, 2018 - 2030 (USD Million)
Table 28 Norway non-opioid pain patches market, by patch type, 2018 - 2030 (USD Million)
Table 29 Norway Non-opioid pain patches market, by distribution channel, 2018 - 2030 (USD Million)
Table 30 Denmark non-opioid pain patches market, by patch type, 2018 - 2030 (USD Million)
Table 31 Denmark non-opioid pain patches market, by distribution channel, 2018 - 2030 (USD Million)
Table 32 Sweden non-opioid pain patches market, by patch type, 2018 - 2030 (USD Million)
Table 33 Sweden non-opioid pain patches market, by distribution channel, 2018 - 2030 (USD Million)
Table 34 Asia Pacific non-opioid pain patches market, by country, 2018 - 2030 (USD Million)
Table 35 Asia Pacific non-opioid pain patches market, by patch type, 2018 - 2030 (USD Million)
Table 36 Asia Pacific non-opioid pain patches market, by distribution channel, 2018 - 2030 (USD Million)
Table 37 Japan non-opioid pain patches market, by patch type, 2018 - 2030 (USD Million)
Table 38 Japan non-opioid pain patches market, by distribution channel, 2018 - 2030 (USD Million)
Table 39 China non-opioid pain patches market, by patch type, 2018 - 2030 (USD Million)
Table 40 China non-opioid pain patches market, by distribution channel, 2018 - 2030 (USD Million)
Table 41 India non-opioid pain patches market, by patch type, 2018 - 2030 (USD Million)
Table 42 India non-opioid pain patches market, by distribution channel, 2018 - 2030 (USD Million)
Table 43 Australia non-opioid pain patches market, by patch type, 2018 - 2030 (USD Million)
Table 44 Australia non-opioid pain patches market, by distribution channel, 2018 - 2030 (USD Million)
Table 45 South Korea non-opioid pain patches market, by patch type, 2018 - 2030 (USD Million)
Table 46 South Korea non-opioid pain patches market, by distribution channel, 2018 - 2030 (USD Million)
Table 47 Thailand non-opioid pain patches market, by patch type, 2018 - 2030 (USD Million)
Table 48 Thailand non-opioid pain patches market, by distribution channel, 2018 - 2030 (USD Million)
Table 49 Latin America non-opioid pain patches market, by country, 2018 - 2030 (USD Million)
Table 50 Latin America non-opioid pain patches market, by patch type, 2018 - 2030 (USD Million)
Table 51 Latin America non-opioid pain patches market, by distribution channel, 2018 - 2030 (USD Million)
Table 52 Brazil non-opioid pain patches market, by patch type, 2018 - 2030 (USD Million)
Table 53 Brazil non-opioid pain patches market, by distribution channel, 2018 - 2030 (USD Million)
Table 54 Argentina non-opioid pain patches market, by patch type, 2018 - 2030 (USD Million)
Table 55 Argentina non-opioid pain patches market, by distribution channel, 2018 - 2030 (USD Million)
Table 56 Middle East & Africa Non-opioid pain patches market, by country, 2018 - 2030 (USD Million)
Table 57 Middle East & Africa non-opioid pain patches market, by patch type, 2018 - 2030 (USD Million)
Table 58 Middle East & Africa non-opioid pain patches market, by distribution channel, 2018 - 2030 (USD Million)
Table 59 South Africa non-opioid pain patches market, by patch type, 2018 - 2030 (USD Million)
Table 60 South Africa non-opioid pain patches market, by distribution channel, 2018 - 2030 (USD Million)
Table 61 Saudi Arabia non-opioid pain patches market, by patch type, 2018 - 2030 (USD Million)
Table 62 Saudi Arabia non-opioid pain patches market, by distribution channel, 2018 - 2030 (USD Million)
Table 63 UAE non-opioid pain patches market, by patch type, 2018 - 2030 (USD Million)
Table 64 UAE non-opioid pain patches market, by distribution channel, 2018 - 2030 (USD Million)
Table 65 Kuwait non-opioid pain patches market, by patch type, 2018 - 2030 (USD Million)
Table 66 Kuwait non-opioid pain patches market, by distribution channel, 2018 - 2030 (USD Million)
List of Figures
Fig. 1 Non-opioid pain patches market segmentation
Fig. 2 Market research process
Fig. 3 Data triangulation techniques
Fig. 4 Primary research pattern
Fig. 5 Market research approaches
Fig. 6 Value-chain-based sizing & forecasting
Fig. 7 Market formulation & validation
Fig. 8 Market snapshot
Fig. 9 Patch type and distribution channel outlook (USD Million)
Fig. 10 Competitive landscape
Fig. 11 Non-opioid pain patches market dynamics
Fig. 12 Non-opioid pain patches market: Porter’s five forces analysis
Fig. 13 Non-opioid pain patches market: PESTLE analysis
Fig. 14 Non-opioid pain patches market: Patch type segment dashboard
Fig. 15 Non-opioid pain patches market: Patch type market share analysis, 2024 & 2030
Fig. 16 Lidocaine patches market, 2018 - 2030 (USD Million)
Fig. 17 Diclofenac patches market, 2018 - 2030 (USD Million)
Fig. 18 Methyl salicylate patches market, 2018 - 2030 (USD Million)
Fig. 19 Capsaicin patches market, 2018 - 2030 (USD Million)
Fig. 20 Ketoprofen patches market, 2018 - 2030 (USD Million)
Fig. 21 Others (herbal, menthol, etc.) market, 2018 - 2030 (USD Million)
Fig. 22 Non-opioid pain patches market: Distribution channel segment dashboard
Fig. 23 Non-opioid pain patches market: Distribution channel market share analysis, 2024 & 2030
Fig. 24 Retail pharmacies market, 2018 - 2030 (USD Million)
Fig. 25 Hospital pharmacies market, 2018 - 2030 (USD Million)
Fig. 26 Online pharmacies market, 2018 - 2030 (USD Million)
Fig. 27 Others (supermarkets/hypermarkets, DTC) market, 2018 - 2030 (USD Million)
Fig. 28 Non-opioid pain patches market revenue, by region
Fig. 29 Regional marketplace: Key takeaways
Fig. 30 Regional marketplace: Key takeaways
Fig. 31 North America non-opioid pain patches market, 2018 - 2030 (USD Million)
Fig. 32 U.S. country dynamics
Fig. 33 U.S. non-opioid pain patches market, 2018 - 2030 (USD Million)
Fig. 34 Canada country dynamics
Fig. 35 Canada non-opioid pain patches market, 2018 - 2030 (USD Million)
Fig. 36 Mexico country dynamics
Fig. 37 Mexico non-opioid pain patches market, 2018 - 2030 (USD Million)
Fig. 38 Europe non-opioid pain patches market, 2018 - 2030 (USD Million)
Fig. 39 UK country dynamics
Fig. 40 UK non-opioid pain patches market, 2018 - 2030 (USD Million)
Fig. 41 Germany country dynamics
Fig. 42 Germany non-opioid pain patches market, 2018 - 2030 (USD Million)
Fig. 43 France country dynamics
Fig. 44 France non-opioid pain patches market, 2018 - 2030 (USD Million)
Fig. 45 Italy country dynamics
Fig. 46 Italy non-opioid pain patches market, 2018 - 2030 (USD Million)
Fig. 47 Spain country dynamics
Fig. 48 Spain non-opioid pain patches market, 2018 - 2030 (USD Million)
Fig. 49 Norway country dynamics
Fig. 50 Norway non-opioid pain patches market, 2018 - 2030 (USD Million)
Fig. 51 Sweden country dynamics
Fig. 52 Sweden non-opioid pain patches market, 2018 - 2030 (USD Million)
Fig. 53 Denmark country dynamics
Fig. 54 Denmark non-opioid pain patches market, 2018 - 2030 (USD Million)
Fig. 55 Asia Pacific non-opioid pain patches market, 2018 - 2030 (USD Million)
Fig. 56 Japan country dynamics
Fig. 57 Japan non-opioid pain patches market, 2018 - 2030 (USD Million)
Fig. 58 China country dynamics
Fig. 59 China non-opioid pain patches market, 2018 - 2030 (USD Million)
Fig. 60 India country dynamics
Fig. 61 India non-opioid pain patches market, 2018 - 2030 (USD Million)
Fig. 62 Australia country dynamics
Fig. 63 Australia non-opioid pain patches market, 2018 - 2030 (USD Million)
Fig. 64 South Korea country dynamics
Fig. 65 South Korea non-opioid pain patches market, 2018 - 2030 (USD Million)
Fig. 66 Thailand country dynamics
Fig. 67 Thailand non-opioid pain patches market, 2018 - 2030 (USD Million)
Fig. 68 Latin America non-opioid pain patches market, 2018 - 2030 (USD Million)
Fig. 69 Brazil country dynamics
Fig. 70 Brazil non-opioid pain patches market, 2018 - 2030 (USD Million)
Fig. 71 Argentina country dynamics
Fig. 72 Argentina non-opioid pain patches market, 2018 - 2030 (USD Million)
Fig. 73 MEA non-opioid pain patches market, 2018 - 2030 (USD Million)
Fig. 74 South Africa country dynamics
Fig. 75 South Africa non-opioid pain patches market, 2018 - 2030 (USD Million)
Fig. 76 Saudi Arabia country dynamics
Fig. 77 Saudi Arabia non-opioid pain patches market, 2018 - 2030 (USD Million)
Fig. 78 UAE country dynamics
Fig. 79 UAE non-opioid pain patches market, 2018 - 2030 (USD Million)
Fig. 80 Kuwait country dynamics
Fig. 81 Kuwait non-opioid pain patches market, 2018 - 2030 (USD Million)
Fig. 82 Company categorization
Fig. 83 Company market position analysis
Fig. 84 Strategic framework

Companies Mentioned

  • Acorda Therapeutics, Inc.
  • Teva Pharmaceutical Industries Ltd.
  • GSK plc
  • Endo, Inc.
  • Hisamitsu Pharmaceutical Co.,Inc.
  • IBSA Institut Biochimique SA
  • Alkermes
  • Teikoku Pharma
  • Mylan N.V.

Methodology

Loading
LOADING...

Table Information